FDA clears pioglitazone for type-2 diabetes

被引：0
|
作者：
不详
机构：
来源：
DRUG NEWS & PERSPECTIVES | 1999年 / 12卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：370 / 370
页数：1
相关论文
共 50 条
  • [1] FDA clears laser for diabetes monitoring
    不详
    PHOTONICS SPECTRA, 1999, 33 (01) : 20 - 20
  • [2] FDA approves pioglitazone for diabetes
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (17) : 1698 - 1698
  • [3] Pioglitazone reduces dense LDL-Particles in patients with type-2 diabetes
    Winkler, K
    Friedrich, I
    Nauck, P
    Wieland, H
    Maerz, W
    DIABETES, 2001, 50 : A147 - A147
  • [4] Pioglitazone and type 2 diabetes
    不详
    AMERICAN JOURNAL OF NURSING, 2002, 102 (08) : 24AA - 24AA
  • [5] Comparison of the effect of Dapagliflozin and Pioglitazone on the risk of osteoporosis in postmenopausal women with Type-2 diabetes
    Son, Osman
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2023, 39 (05) : 1238 - 1242
  • [6] Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes
    Mahajan, Rajiv
    INDIAN JOURNAL OF PHARMACOLOGY, 2009, 41 (04) : 197 - 198
  • [7] Rosiglitazone or pioglitazone in type 2 diabetes?
    de Vries, Corinne S.
    Russell-Jones, David L.
    BRITISH MEDICAL JOURNAL, 2009, 339
  • [8] Pioglitazone for the treatment of type 2 diabetes
    Nabrdalik, Katarzyna
    Cichocka, Edyta
    Zywiec, Joanna
    Chodkowski, Artur
    Gumprecht, Janusz
    CLINICAL DIABETOLOGY, 2014, 3 (04): : 176 - 180
  • [9] Pioglitazone for type 2 diabetes mellitus
    Richter, B.
    Bandeira-Echtler, E.
    Bergerhoff, K.
    Clar, C.
    Ebrahim, S. H.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (04):
  • [10] Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes
    Gupta, Alok K.
    Bray, George A.
    Greenway, Frank L.
    Martin, Corby K.
    Johnson, William D.
    Smith, Steven R.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2010, 24 (05) : 289 - 296
12345